We are live on ! Find out more
SRPT icon

Sarepta Therapeutics
SRPT

389 hedge funds and large institutions have $9.51B invested in Sarepta Therapeutics in 2019 Q4 according to their latest regulatory filings, with 104 funds opening new positions, 117 increasing their positions, 110 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more first-time investments, than exits

New positions opened: 104 | Existing positions closed: 48

72% more capital invested

Capital invested by funds: $5.52B → $9.51B (+$3.98B)

47% more call options, than puts

Call options by funds: $573M | Put options by funds: $391M

25% more funds holding in top 10

Funds holding in top 10: 8 → 10 (+2)

14% more funds holding

Funds holding: 340 → 389 (+49)

6% more repeat investments, than reductions

Existing positions increased: 117 | Existing positions reduced: 110

0.42% less ownership

Funds ownership: 99.26% → 98.84% (-0.42%)

Holders
389
Holders Change
+49
Holders Change %
+14.41%
% of All Funds
7.67%
Holding in Top 10
10
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+25%
% of All Funds
0.2%
New
104
Increased
117
Reduced
110
Closed
48
Calls
$573M
Puts
$391M
Net Calls
+$182M
Net Calls Change
+$192M

Top Buyers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
+$243M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$95.5M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$87.3M
4
JP Morgan Chase
JP Morgan Chase
New York
+$84.2M
5
Sands Capital Management
Sands Capital Management
Virginia
+$61.1M

Top Sellers

Rank Fund Capital Flow
1
Fidelity International
Fidelity International
Bermuda
-$186M
2
CCM
Cadian Capital Management
New York
-$70.9M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$64.4M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$47.1M
5
PC
Polar Capital
United Kingdom
-$46.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
HIIFS
426
Harel Insurance Investments & Financial Services
Israel
– -$6K -83 Closed
TC
427
Truvestments Capital
Florida
– -$6K -76 Closed
PCG
428
Private Capital Group
Connecticut
– -$5K -72 Closed
WC
429
Weil Company
California
– -$5K -70 Closed
PFO
430
Pathstone Family Office
New Jersey
– -$4K -51 Closed
AIC
431
Archer Investment Corporation
Indiana
– -$3K -35 Closed
GSWM
432
Golden State Wealth Management
California
– -$2K -25 Closed
EW
433
Evoke Wealth
California
– -$1.43K -19 Closed
GWAG
434
Garrett Wealth Advisory Group
Texas
– -$753 -10 Closed
OSAM
435
O'Shaughnessy Asset Management
Connecticut
– +$101 +1 New
14 15 16 17
18

SRPT Hedge Fund Activity: Q4 2019 in Review

389 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q4 2019, worth a combined $9.51B — up 72% from $5.52B a quarter earlier.

Buyers outnumbered sellers: 104 funds opened new SRPT positions and 48 closed out — a net gain of 56 holders — while 117 added to existing stakes and 110 trimmed.

The largest buyer was Capital Research Global Investors, opening a new position worth an estimated $243M. The largest seller was Fidelity International, cutting an estimated $186M.

  • 389 institutional investors held Sarepta Therapeutics (SRPT) as of Q4 2019, up from 340 in Q3 2019.
  • Funds reported $9.51B of Sarepta Therapeutics stock for Q4 2019, up 72% quarter-over-quarter.
  • 104 funds opened new Sarepta Therapeutics positions in Q4 2019 and 48 closed out, a net change of +56 holders.
  • The largest Sarepta Therapeutics buyer in Q4 2019 was Capital Research Global Investors, an estimated $243M added.
  • The largest Sarepta Therapeutics seller in Q4 2019 was Fidelity International, an estimated $186M sold.

Based on aggregated 13F filings for Q4 2019.